☰

Jonathan S. Rink, Ph.D. - Publications

Affiliations: 
2011 Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Genetics, Molecular Biology, Surgery
Tree Info Grants Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Rink JS, Lin AY, Calvert AE, Kwon D, Moxley A, Henrich SE, Mohammadlou A, Zhang XH, Wu X, Querfeld C, Griend DJV, Yin HH, Horne DA, Nguyen ST, Rosen ST, et al. Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1. Acs Applied Materials & Interfaces. PMID 39688216 DOI: 10.1021/acsami.4c15472  0.357
2020 Rink JS, Lin AY, McMahon KM, Calvert AE, Yang S, Taxter T, Moreira J, Chadburn A, Behdad A, Karmali R, Thaxton CS, Gordon LI. Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. The Journal of Biological Chemistry. 296: 100100. PMID 33410414 DOI: 10.1074/jbc.RA120.014888  0.323
2020 Rink JS, Lin A, McMahon KM, Calvert AE, Yang S, Taxter T, Moreira J, Chadburn A, Behdad A, Karmali R, Thaxton CS, Gordon LI. Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. The Journal of Biological Chemistry. PMID 33208460 DOI: 10.1074/jbc.RA120.014888  0.323
2020 Lin AY, Rink JS, Karmali R, Xu J, Kocherginsky M, Thaxton CS, Gordon LI. Tri-ethylene glycol modified class B and class C CpG conjugated gold nanoparticles for the treatment of lymphoma. Nanomedicine : Nanotechnology, Biology, and Medicine. 102290. PMID 32798731 DOI: 10.1016/J.Nano.2020.102290  0.409
2019 Singh A, Nandwana V, Rink JS, Ryoo SR, Chen TH, Allen SD, Scott EA, Gordon LI, Thaxton CS, Dravid VP. Bio-Mimetic Magnetic Nanostructures: A Theranostic Platform Targeting Lipid Metabolism and Immune Response in Lymphoma. Acs Nano. PMID 31487458 DOI: 10.1021/Acsnano.9B03727  0.398
2019 Henrich SE, Hong BJ, Rink JS, Nguyen ST, Thaxton CS. Supramolecular assembly of high-density lipoprotein mimetic nanoparticles using lipid-conjugated core scaffolds. Journal of the American Chemical Society. PMID 31177775 DOI: 10.1021/Jacs.9B00651  0.385
2019 Rink J, Lin AY, Yang S, Behdad A, Karmali R, Thaxton CS, Gordon LI. Bio-Inspired Functional Lipoprotein-like Nanoparticles (Flip-NPs) Cause Cholesterol Starvation and Ferroptosis in B-Cell Lymphomas: Studies in Cell Lines, Xenograft Models and Primary Patient Samples Blood. 134: 2857-2857. DOI: 10.1182/Blood-2019-127805  0.449
2019 Lin AY, Rink J, Karmali R, Thaxton CS, Gordon LI. Engineering CpG Deoxynucleotide-Conjugated Gold Nanoparticles for Enhanced Anti-Lymphoma Effects in an Immune Competent Lymphoma Model Blood. 134: 1577-1577. DOI: 10.1182/Blood-2019-125308  0.384
2019 Rink JS, Yang S, Lin A, Karmali R, Thaxton CS, Gordon LI. Abstract 3618: The mechanism of functional lipoprotein-like nanoparticle (FLip-NP) induced lymphoma cell death Cancer Research. 79: 3618-3618. DOI: 10.1158/1538-7445.Am2019-3618  0.425
2018 Rink JS, Sun W, Misener S, Wang JJ, Zhang ZJ, Kibbe MR, Dravid VP, Venkatraman SS, Thaxton CS. Nitric Oxide-Delivering High-Density Lipoprotein-Like Nanoparticles as a Biomimetic Nanotherapy for Vascular Disease. Acs Applied Materials & Interfaces. PMID 29385802 DOI: 10.1021/Acsami.7B18525  0.417
2018 Bell JB, Rink JS, Eckerdt F, Clymer J, Goldman S, Thaxton CS, Platanias LC. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma. Scientific Reports. 8: 1211. PMID 29352211 DOI: 10.1038/S41598-017-18100-8  0.441
2018 Rink J, Yang S, Cen O, Karmali R, Thaxton CS, Gordon LI. Inhibition of Pro-Survival Pathways in DLBCL Cells By Functional Lipoprotein-like Nanoparticles Blood. 132: 1668-1668. DOI: 10.1182/Blood-2018-99-119122  0.439
2018 Palekar RU, Rink JS, McMahon KM, Thaxton CS. Abstract 392: Nanoparticle-based Biosensors for Measuring Apolipoprotein A-I and HDL Function Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.392  0.355
2017 Rink JS, Yang S, Cen O, Taxter T, McMahon KM, Misener S, Behdad A, Longnecker R, Gordon LI, Thaxton CS. Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin. Molecular Pharmaceutics. PMID 28933554 DOI: 10.1021/Acs.Molpharmaceut.7B00710  0.445
2017 Meyers MW, Rink JS, Jiang Q, Kelly ME, Vercammen JM, Thaxton CS, Kibbe MR. Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions. Physiological Reports. 5. PMID 28242820 DOI: 10.14814/Phy2.13128  0.318
2017 Rink J, Cen O, McMahon KM, Misener S, Yang S, Thaxton CS, Gordon LI. Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled By Functional Lipoprotein Nanoparticles and the B Cell Receptor Inhibitor Ibrutinib: A Therapeutic Strategy Dependent on Cell of Origin (COO) Blood. 130: 576-576. DOI: 10.1182/Blood.V130.Suppl_1.576.576  0.426
2016 Sun W, Wu W, McMahon KM, Rink JS, Thaxton CS. Mosaic Interdigitated Structure in Nanoparticle-Templated Phospholipid Bilayer Supports Partial Lipidation of Apolipoprotein A-I. Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems. 33: 300-305. PMID 28781432 DOI: 10.1002/Ppsc.201600032  0.376
2016 Thaxton CS, Rink JS, Naha PC, Cormode DP. Lipoproteins and lipoprotein mimetics for imaging and drug delivery. Advanced Drug Delivery Reviews. PMID 27133387 DOI: 10.1016/J.Addr.2016.04.020  0.363
2016 Rink JS, Misener S, Cen O, Yang S, Gordon LI, Thaxton CS. High Density Lipoprotein-like Nanoparticles Synergize with Akt and Btk Inhibitors to Induce Cell Death in Diffuse Large B Cell Lymphomas Blood. 128: 3022-3022. DOI: 10.1182/Blood.V128.22.3022.3022  0.446
2016 Wasserman MA, Rink J, Thaxton CS, Kibbe MR. Synthetically Engineered High-Density Lipoprotein Gold Nanoparticles Target to Vascular Injury after Systemic Intravascular Administration Journal of the American College of Surgeons. 223: S169. DOI: 10.1016/J.Jamcollsurg.2016.06.033  0.35
2016 Sun W, Wu W, McMahon KM, Rink JS, Thaxton CS. Templated Phospholipid Bilayers: Mosaic Interdigitated Structure in Nanoparticle-Templated Phospholipid Bilayer Supports Partial Lipidation of Apolipoprotein A-I (Part. Part. Syst. Charact. 6/2016) Particle and Particle Systems Characterization. 33: 295. DOI: 10.1002/Ppsc.201670017  0.344
2015 Kaufman DB, Rink JS. Emergence of naturally occurring scaffolds for cell transplantation in type 1 diabetes. Pediatric Transplantation. 19: 345-7. PMID 25940373 DOI: 10.1111/Petr.12451  0.477
2015 Rink JS, Yang S, Cen O, Ying F, Chae YK, Scholtens D, Moreira J, Chadburn A, Gordon LI, Thaxton CS. Scavenger Receptor Type B1 Is Essential for High Density Lipoprotein Nanoparticle Induced B-Cell Lymphoma Cell Death Blood. 126: 2756-2756. DOI: 10.1182/Blood.V126.23.2756.2756  0.416
2015 Chae YK, Pan A, Scholtens D, Yang S, Rink J, Thaxton CS, Gordon L. Abstract 3672: Expression patterns of scavenger receptor B-1 (SR-B1) to guide biomimetic HDL gold nanoparticle therapy Cancer Research. 75: 3672-3672. DOI: 10.1158/1538-7445.Am2015-3672  0.389
2015 Wasserman MA, Jiang Q, Rink J, Kibbe MR, Thaxton CS. Synthetically Engineered Targeted Gold Nanoparticles for the Prevention of Restenosis after Vascular Interventions Journal of the American College of Surgeons. 221: S185. DOI: 10.1016/J.Jamcollsurg.2015.07.440  0.329
2013 Rink JS, McMahon KM, Zhang X, Chen X, Mirkin CA, Thaxton CS, Kaufman DB. Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival. Transplantation. 96: 877-84. PMID 24247900 DOI: 10.1097/Tp.0B013E3182A4190E  0.567
2013 Rink JS, Plebanek MP, Tripathy S, Thaxton CS. Update on current and potential nanoparticle cancer therapies. Current Opinion in Oncology. 25: 646-51. PMID 24097107 DOI: 10.1097/Cco.0000000000000012  0.342
2013 Yang S, Damiano MG, Zhang H, Tripathy S, Luthi AJ, Rink JS, Ugolkov AV, Singh AT, Dave SS, Gordon LI, Thaxton CS. Biomimetic, synthetic HDL nanostructures for lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 110: 2511-6. PMID 23345442 DOI: 10.1073/Pnas.1213657110  0.464
2012 Rink JS, Chen X, Zhang X, Kaufman DB. Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant. Surgery. 151: 330-9. PMID 21982523 DOI: 10.1016/J.Surg.2011.07.011  0.514
2011 Rink J, Chen X, Zhang X, Kaufman D. Conditional and Specific Inhibition Of NF-kB Prevents Cytokine-Induced Deleterious Gene Expression And Improves Islet Survival In Vitro And Post-Transplant Journal of Surgical Research. 165: 181. DOI: 10.1016/j.jss.2010.11.705  0.474
2010 Rink JS, McMahon KM, Chen X, Mirkin CA, Thaxton CS, Kaufman DB. Transfection of pancreatic islets using polyvalent DNA-functionalized gold nanoparticles. Surgery. 148: 335-45. PMID 20633730 DOI: 10.1016/J.Surg.2010.05.013  0.531
2010 Rink J, McMahon K, Chen X, Thaxton C, Kaufman D. Nanogold Particles as a Genetic Therapy Delivery Agent for Human Pancreatic Islets Journal of Surgical Research. 158: 202-203. DOI: 10.1016/J.Jss.2009.11.097  0.457
2009 Rink J, Chen X, Kaufman D. QS184. NF-KappaB Mediates Glucose-Induced Pancreatic Beta Cell Proliferation Journal of Surgical Research. 151: 290. DOI: 10.1016/J.Jss.2008.11.484  0.431
Show low-probability matches.